Whoop Secures $575M Series G at $10.1B Valuation with Abbott Investment
Whoop raised $575 million in a Series G funding round at a $10.1 billion valuation, with Abbott Laboratories among investors. The funding will back R&D, marketing and international expansion as the subscription health platform aims to accelerate AI-powered monitoring and maintain cash flow positivity.
1. Series G Funding and Valuation
In a Series G equity round, Whoop raised $575 million at a $10.1 billion valuation, nearly triple its $3.6 billion valuation in 2021. Investors include Qatar Investment Authority, Mubadala, Abbott Laboratories and high-profile athletes.
2. Membership and Financial Performance
Whoop has grown to over 2.5 million subscribers and achieved cash flow positivity in 2025, driven by a 103% year-over-year increase in subscriptions and bookings, lifting its revenue run rate to $1.1 billion.
3. Strategic Fit for Abbott Laboratories
Abbott’s participation aligns with its commitment to proactive health monitoring, potentially enabling integration of wearable data into its diagnostics and medical device portfolio as Whoop advances AI-driven health insights.
4. Expansion, Hiring and Regulatory Outlook
Whoop plans to expand its workforce by up to 75%, add over 600 roles and scale sales internationally—now 60% of revenue from 60 countries—while navigating FDA discussions over blood pressure monitoring features in its devices.